{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:37:27Z","timestamp":1771943847695,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s11655-009-0063-3","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T09:15:07Z","timestamp":1236330907000},"page":"63-65","source":"Crossref","is-referenced-by-count":6,"title":["Clinical observation on the treatment of male neoplastic anemia with Yixuesheng capsule (\u76ca\u8840\u751f\u80f6\u56ca) combined with recombination human erythropoietin"],"prefix":"10.1007","volume":"15","author":[{"given":"Zhi","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-fa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,7]]},"reference":[{"key":"63_CR1","first-page":"461","volume":"13","author":"J. Glasyp","year":"1999","unstructured":"Glasyp J, Cavill I. Role of iron in optimizing responses of anemic cancer patients to erythropoietin. Oncology 1999;13:461\u2013473.","journal-title":"Oncology"},{"issue":"3suppl7","key":"63_CR2","first-page":"35","volume":"25","author":"H. Ludwig","year":"1998","unstructured":"Ludwig H, Fritz E. Anemia of cancer patients: patient selection and patient stratification for epoetin treatment. Semin Oncol 1998;25(3 suppl 7):35\u201338.","journal-title":"Semin Oncol"},{"issue":"3","key":"63_CR3","first-page":"295","volume":"11","author":"H.Y. Zhang","year":"2004","unstructured":"Zhang HY, Meng QX, Liu J, Pang LP, Yang BQ. Study on the serum erythropoietin and testoserone in patients with anemia of cancer. Chin J Prim Med Pharm (Chin) 2004;11(3):295\u2013296.","journal-title":"Chin J Prim Med Pharm (Chin)"},{"key":"63_CR4","first-page":"1","volume-title":"Standard for diagnosis and therapeutic efficacy evaIuation of hematopathy","year":"1998","unstructured":"Zhang ZN, Shen T, ed. Standard for diagnosis and therapeutic efficacy evaIuation of hematopathy. 2nd ed. Beiiing: Publishing House of Science; 1998:1\u20135.","edition":"2nd ed."},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/clim.1999.4736","volume":"92","author":"P.V. Voulgari","year":"1999","unstructured":"Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA. Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol 1999;92:153\u2013160.","journal-title":"Clin Immunol"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","volume":"80","author":"R.T. Means Jr","year":"1992","unstructured":"Means RT Jr, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639\u20131647.","journal-title":"Blood"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2169\/internalmedicine.43.649","volume":"43","author":"W. Jelkmann","year":"2004","unstructured":"Jelkmann W. Molecular biology of erythropoietin. Intern Med 2004;43:649\u2013659.","journal-title":"Intern Med"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","volume":"19","author":"T.J. Littlewood","year":"2001","unstructured":"Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B, Epoetin Alfa Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865\u20132874.","journal-title":"J Clin Oncol"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2001.19.11.2875","volume":"19","author":"J.L. Gabrilove","year":"2001","unstructured":"Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001;19:2875\u20132882.","journal-title":"J Clin Oncol"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-009-0063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-009-0063-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-009-0063-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:20:09Z","timestamp":1589631609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-009-0063-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11655-009-0063-3","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}